Alan B. Lancz & Associates, Inc. 23and Me Holding Co. Transaction History

Alan B. Lancz & Associates, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$0.71 - $0.97 $1,846 - $2,522	-2,600 Reduced 17.45%	12,300 $11,000
Q3 2023 Nov 13, 2023	SELL	$0.96 - $2.01 $7,776 - $16,280	-8,100 Reduced 35.22%	14,900 $14,000
Q2 2023 Aug 09, 2023	BUY	$1.59 - $2.29 $36,570 - $52,670	23,000 New	23,000 $40,000

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.